# Thermo Fisher Scientific invests $50M to expand biologics manufacturing in St. Louis

Thermo Fisher Scientific is investing $50 million to expand its St. Louis, Missouri site, adding 64,000 square feet to double manufacturing capacity and create 80 new jobs, with operations expected in 2019.

- Type: Expansion
- Announced: 2018-04-23
- Where: St. Louis, Missouri, United States
- Value: $50.0M
- Jobs: 80
- Starts operating: 2019
- Status: announced
- Capacity: double manufacturing capacity
- Products: biologic drug substances
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Thermo Fisher Scientific](https://endata.com/companies/7061.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/thermo-fisher-scientific-announces-50-million-investment-to-enhance-biologics-capabilities-300634190.html), 2018-04-23: "Thermo Fisher Scientific announced today that is investing $50 million in its St. Louis, Missouri site which is one of the company's Centers of Excellence for Biological Commercial Manufacturing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.